Medical Costs of Oral Anticoagulants vs Warfarin for Atrial Fibrillation Patients with Different Stroke Risks

INTRODUCTION: The Apixaban for the Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE), Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY), and Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention...

Descripción completa

Detalles Bibliográficos
Autores principales: Deitelzweig, Steve, Amin, Alpesh, Jing, Yonghua, Makenbaeva, Dinara, Wiederkehr, Daniel, Lin, Jay, Graham, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107424/
https://www.ncbi.nlm.nih.gov/pubmed/25135394
http://dx.doi.org/10.1007/s40119-013-0020-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107424/
https://www.ncbi.nlm.nih.gov/pubmed/25135394
http://dx.doi.org/10.1007/s40119-013-0020-5

Ejemplares similares